Multimodal Neuroimaging in Rett Syndrome With MECP2 Mutation

Area of Science:

• Neuroscience
• Medical Imaging
• Genetics

Background:

• Rett syndrome (RTT) is a rare neurodevelopmental disorder caused by *MECP2* gene mutations, leading to severe cognitive, social, and physical impairments.
• Current research focuses on identifying diagnostic markers, therapeutic targets, and efficacy indicators for RTT.
• Neuroimaging plays a crucial role in understanding RTT's brain structure, function, and genotype-phenotype correlations.

Purpose of the Study:

• To review existing neuroimaging literature on Rett syndrome.
• To synthesize findings on brain structure, function, and metabolic alterations in RTT.
• To identify limitations and future directions for RTT neuroimaging research.

Main Methods:

• Systematic review of neuroimaging studies (MRI, DTI, SPECT, PET, MRS) in RTT patients.
• Analysis of morphologic, microstructural, perfusion, and metabolic brain changes.
• Exploration of genotype-phenotype associations through imaging data.

Main Results:

• MRI studies show global gray and white matter atrophy with regional maturation variations.
• Diffusion tensor imaging (DTI) reveals reduced fractional anisotropy (FA) in specific white matter tracts, correlating with behavioral issues.
• Cerebral blood flow (CBF) is decreased, particularly in prefrontal and temporoparietal regions; metabolic alterations are also noted.

Conclusions:

• Multimodal neuroimaging offers insights into the complex interplay of genes, neurotransmitters, behavior, and clinical severity in RTT.
• Limitations include small sample sizes and region-specific approaches.
• Future research requires larger, multimodal/multisequence studies, potentially combining PET-MRI, to fully elucidate RTT brain alterations.